Publications by authors named "Julius C EnSSle"

Claim this Profile
G
Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapy.
Stefan Enssle, Anna Sax, Peter May, Nadia El Khawanky, Nardine Soliman, Julius C Enssle

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and outcomes of Candida spp. bloodstream infections in cancer patients: a comparative retrospective study from a German tertiary cancer center.
Sebastian Wolf, Sarah Weber, Aaron Janetta, Friederike Klein, Julius C Enssle

Infection· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses after one versus two Influenza A/B vaccinations in patients with multiple myeloma.
Julius C Enssle, Tonio Brinkschmidt, Ralf Dürrwald, Sebastian Wolf, David Zurmeyer

Ann Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy.
Fabian Acker, Jörg Chromik, Emily Tiedjen, Sebastian Wolf, Jonas B Vischedyk

Eur J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy.
James D Phelan, Sebastian Scheich, Jaewoo Choi, George W Wright, Björn Häupl, Julius C Enssle

Cancer Cell· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients.
Julius C Enssle, Julia Campe, Alina Moter, Isabel Voit, Alec Gessner

Leukemia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Julius C Enßle, Sebastian Wolf, Sebastian Scheich, Sarah Weber, Michael Kramer

Br J Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML.
Anjali Cremer, Julius C Enssle, Saskia Pfaff, Khouloud Kouidri, Fabian Lang

Ann Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.
Sebastian Scheich, Jiji Chen, Jiamin Liu, Frank Schnütgen, Julius C Enssle

Cancer Discov· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma.
Julius C Enssle, Julia Campe, Sarah Büchel, Alina Moter, Frederic See

Cancer Cell· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proteogenomic subtypes of acute myeloid leukemia.
Ashok Kumar Jayavelu, Sebastian Wolf, Florian Buettner, Gabriela Alexe, Björn Häupl, Julius C Enssle

Cancer Cell· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma.
Julius C Enßle, Julia Campe, Amelie Schwenger, Eliza Wiercinska, Helen Hellstern

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High CD34 positive stem cell dosage improves thrombocyte recovery in obese myeloma patients undergoing autologous stem cell transplantation.
Julius C Enßle, Sebastian Wolf, Ivana von Metzler, Sarah Weber, Heike Bialleck

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation.
Sarah Weber, Sebastian Scheich, Aaron Magh, Sebastian Wolf, Julius C Enßle

Int J Infect Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells.
Cathinka Boedicker, Michelle Hussong, Christina Grimm, Nadezda Dolgikh, Michael T Meister

Oncogene· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity is associated with an impaired survival in lymphoma patients undergoing autologous stem cell transplantation.
Sebastian Scheich, Julius C Enßle, Victoria T Mücke, Fabian Acker, Lukas Aspacher

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells.
Julius C Enßle, Cathinka Boedicker, Marek Wanior, Meike Vogler, Stefan Knapp

Cancer Lett· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis